• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Roche

Podcast
Fierces The Top Line logo appears over a pale yellow background patterned with diagonal yellow capsules
Podcast

GSK's twin FDA wins, Roche's $15B deal and point-of-care ads

This week on "The Top Line": GSK's pair of FDA approvals, Roche's $15 billion ADC deal and the rise of point-of-care pharma marketing.
Ayla Ellison , Zoey Becker Oct 23, 2026 9:28am
Roches headquarters in Basel sunset in the background

Vabysmo shows signs of recovery as Roche gears up for busy 2027

Oct 22, 2026 11:20am
euro

Roche pauses future Germany investments

Oct 19, 2026 10:25am
Close-up of human eye

Roche's Enspryng muscles in on Tepezza's TED turf

Oct 16, 2026 9:26am
Asia

Roche, Asahi Kasei, Verastem—Fierce Pharma Asia

Oct 16, 2026 7:57am
pivot change turnaround direction walk away

Roche's Gazyva secures FDA nod in 2nd autoimmune indication

Sep 28, 2026 2:29pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings